DEXAMETHASONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dexamethasone Acetate, and what generic alternatives are available?
Dexamethasone Acetate is a drug marketed by Watson Labs and Watson Labs Teva and is included in two NDAs.
The generic ingredient in DEXAMETHASONE ACETATE is dexamethasone acetate. There are thirty-nine drug master file entries for this compound. Additional details are available on the dexamethasone acetate profile page.
Summary for DEXAMETHASONE ACETATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Clinical Trials: | 81 |
Patent Applications: | 2,445 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXAMETHASONE ACETATE at DailyMed |
Recent Clinical Trials for DEXAMETHASONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | N/A |
Antengene Corporation | Phase 1/Phase 2 |
Xia Zhongjun | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DEXAMETHASONE ACETATE
US Patents and Regulatory Information for DEXAMETHASONE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | DEXAMETHASONE ACETATE | dexamethasone acetate | INJECTABLE;INJECTION | 084315-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Teva | DEXAMETHASONE ACETATE | dexamethasone acetate | INJECTABLE;INJECTION | 087711-001 | May 24, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |